05/02/2025 13:51
Decent Cybersecurity Joins the Council of Slovak Exporters to Strengthen European Cybersecurity Exports

Decent Cybersecurity, a leading European provider of post-quantum security solutions, announces its membership in the Council of Slovak Exporters (CSE), reinforcing its commitment to expanding advanced cybersecurity exports across global markets. This strategic partnership combines Decent Cybersecurity's expertise in critical infrastructure protection with CSE's established export promotion platform. As a company holding national, EU, and NATO "Secret" level security clearances, Decent Cyberse...

05/07/2025 08:30
Allied Telesis Invests in Sales Enablement Platform With Intangi Eco-System

Today, Allied Telesis, a global leader in connectivity solutions and intelligent networking tools, is significantly enhancing its channel partner ecosystem with the adoption of the Intangi Iris configuration, design, and quoting platform. This strategic investment will enable partners to create Allied Telesis and other best-of-breed multi-vendor solutions tailored to their customers’ need and underscores the company’s commitment to empowering its partners with cutting-edge tools to help drive m...

06/13/2025 03:33
xFusion Unveils Breakthrough High-Performance Computing Innovations at ISC 2025

xFusion International Pte. Ltd (xFusion) showcased its latest advancements in high-performance computing (HPC) and sustainable intelligent computing solutions at the International Supercomputing Conference (ISC) 2025, held from June 10 to 13 in Hamburg, Germany. As a global leader in HPC and computing infrastructure, xFusion highlighted its commitment to empowering industries and institutions with cutting-edge technologies that accelerate innovation and digital transformation. This press relea...

06/05/2025 13:00
Capcom’s New Sci-Fi Action-Adventure Game PRAGMATA to Launch in 2026!

Capcom Co., Ltd. (TOKYO:9697) today announced that PRAGMATA, a highly anticipated all-new IP, is scheduled for release in 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250605459835/en/ PRAGMATA Key Art PRAGMATA is a sci-fi action-adventure game that takes place on the moon in a near-future world. In the game, two compel...

06/10/2025 12:31
Fortis Healthcare Recognized for its Global Contribution to Medical Value Travel at Advantage Healthcare India 2025

Advantage Healthcare India 2025, an International Summit dedicated to advancing India's position as a global hub for medical value travel has recognized Fortis Healthcare’s global contribution to medical value travel, where Fortis has contributed to India's reputation as a leading destination for medical tourism. Fortis Healthcare bagged Advantage Healthcare India's Medical Value Travel Awards 2025 in 7 categories. Fortis Escorts Heart Institute, Okhla was recognized for its contribution t...

06/10/2025 12:30
Hypernative Raises $40M Series B to Remove Security Barriers to Web3 Mass Adoption

Hypernative, the leading provider of real-time threat prevention in Web3, today announced a $40 million Series B funding round co-led by Ten Eleven Ventures and Ballistic Ventures, with participation from StepStone Group, and existing investors boldstart ventures and IBI Tech Fund. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250610162307/en/Hypernative team The funds will support the expansion of the company’s offering to include...

05/07/2025 09:00
AACR 2025: Brenus Pharma Presents Late-breaking Preclinical Data on its “off-the-shelf” Next-generation Vaccine-based Immunotherapy Candidate, STC-1010, Now Moving to Clinic

Brenus Pharma, a French clinical-stage biotechnology company, presented new preclinical data on its lead immunotherapy candidate, STC-1010, during the Late-Breaking Research: Immunology 3 session at the AACR Annual Meeting 2025, held April 25–30 in Chicago, IL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507231535/en/George Alzeeb, PhD, Innovation Manager at Brenus Pharma, presenting the company’s latest preclinical data on STC...